SARS-Coronavirus-2 Nsp13 Possesses NTPase and RNA Helicase Activities That Can Be Inhibited by Bismuth Salts

Ting Shu(Chinese Academy of Sciences), Xi Zhou(Wuhan Institute of Virology), Ruibing Wang(University of Macau), Dingyu Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Jingfang Mu(Chinese Academy of Sciences), Di Wu(Chinese PLA General Hospital), Yang Han(Nanfang Hospital), Muhan Huang(Chinese Academy of Sciences), Yujie Ren(Wuhan Institute of Virology), Xueyi Zhang(Chinese Academy of Sciences), Yang Qiu(Beijing Proteome Research Center)
Virologica Sinica
June 1, 2020
10.1007/s12250-020-00242-1
Cited by 190

Related Papers

RETRACTED: 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study
|The Lancet|2021|4.3k
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
|The Lancet|2020|3.7k
SARS-CoV-2 and viral sepsis: observations and hypotheses
|The Lancet|2020|1.2k
Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma
|Nature|2019|982
6-month consequences of COVID-19 in patients discharged from hospital: a cohort study
|The Lancet|2023|892